carglumic acid 200 MG Tablet for Oral Suspension [Carbaglu]
carglumic acid
RxCUI: 905394
What the CMS Formulary Data Shows for carglumic acid 200 MG Tablet for Oral Suspension [Carbaglu]
Per the CMS 2026 Part D formulary file, carglumic acid 200 MG Tablet for Oral Suspension [Carbaglu] (RxNorm concept RXCUI 905394, generic name carglumic acid) appears on 3 distinct formulary files spanning 12 Medicare Part D plan offerings - 0.2% of enrollable Part D products, selective placement; verify formulary inclusion before enrolling. Tier placement ranges from Tier 1 to Tier 5, with a cross-plan average of Tier 2.3.
Real-world access to carglumic acid 200 MG Tablet for Oral Suspension [Carbaglu] depends on utilization management as much as tier placement: 100% of covering formularies require prior authorization. 0% require step therapy. 0% apply quantity limits.
Medicare Part D spending dashboard figures are not published for this drug. The plan-by-plan detail below lists exactly which PDP and MA-PD contracts carry carglumic acid 200 MG Tablet for Oral Suspension [Carbaglu] today.
Coverage Details
- Formularies covering
- 3
- Plans covering
- 12
- Coverage rate
- 0.2%
- Tier range
- Tier 1 – Tier 5
- Average tier
- Tier 2, Generic
Restrictions
- Prior authorization required
- 100% of formularies
- Step therapy required
- 0% of formularies
- Quantity limits
- 0% of formularies
Tier Distribution Across Plans
Medicare Advantage Plans (MA-PD) Covering carglumic acid 200 MG Tablet for Oral Suspension [Carbaglu]
12 Medicare Advantage plans with Part D drug coverage include this drug.
| Plan | Insurer | Tier | PA | Premium | States |
|---|---|---|---|---|---|
| Hamaspik Medicare Choice (HMO D-SNP) | HAMASPIK, INC. | T1 | Yes | $0 | NY |
| Platino Blindao (HMO D-SNP) | TRIPLE S ADVANTAGE, INC. | T1 | Yes | $0 | PR |
| Platino Enlace (HMO D-SNP) | TRIPLE S ADVANTAGE, INC. | T1 | Yes | $0 | PR |
| PLATINO ADVANCE (HMO D-SNP) | TRIPLE S ADVANTAGE, INC. | T1 | Yes | $0 | PR |
| PLATINO PLUS (HMO D-SNP) | TRIPLE S ADVANTAGE, INC. | T1 | Yes | $0 | PR |
| Hamaspik Medicare Select (HMO D-SNP) | HAMASPIK, INC. | T1 | Yes | $34.50 | NY |
| Óptimo Plus (PPO) | TRIPLE S ADVANTAGE, INC. | T5 | Yes | $0 | PR |
| Contigo Plus (HMO C-SNP) | TRIPLE S ADVANTAGE, INC. | T5 | Yes | $0 | PR |
| Brillante (HMO-POS) | TRIPLE S ADVANTAGE, INC. | T5 | Yes | $0 | PR |
| Enlace Plus (HMO) | TRIPLE S ADVANTAGE, INC. | T5 | Yes | $0 | PR |
| ContigoEnMente (HMO C-SNP) | TRIPLE S ADVANTAGE, INC. | T5 | Yes | $0 | PR |
| Ahorro Plus (HMO) | TRIPLE S ADVANTAGE, INC. | T5 | Yes | $0 | PR |
Frequently Asked Questions
Is carglumic acid 200 MG Tablet for Oral Suspension [Carbaglu] covered by Medicare Part D?
Yes, carglumic acid 200 MG Tablet for Oral Suspension [Carbaglu] is covered by 12 Medicare Part D plans (0.2% of all Part D formularies).
What tier is carglumic acid 200 MG Tablet for Oral Suspension [Carbaglu] on Medicare Part D plans?
carglumic acid 200 MG Tablet for Oral Suspension [Carbaglu] averages Tier 2.3 across Part D plans, ranging from Tier 1 to Tier 5.
Does carglumic acid 200 MG Tablet for Oral Suspension [Carbaglu] require prior authorization?
100% of Part D formularies require prior authorization for carglumic acid 200 MG Tablet for Oral Suspension [Carbaglu]. Step therapy: 0%. Quantity limits: 0%.
Read our methodology - how this data is sourced, computed, and verified.